Search results
Results From The WOW.Com Content Network
CHS is a paradoxical syndrome characterized by hyperemesis (persistent vomiting), as opposed to the better known antiemetic properties of cannabinoids. [15] The most prominent CHS symptoms are cyclical nausea, vomiting, and abdominal pain, concomitant with chronic cannabinoid use. [15]
An antiemetic is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, and chemotherapy directed against cancer. They may be used for severe cases of gastroenteritis, especially if the patient is dehydrated. [1] [2]
Aprepitant has been identified as having strong potential in treating protracted vomiting episodes in individuals with cannabinoid hyperemesis syndrome. [25] This syndrome is characterized by nausea, cyclical vomiting, and cramping abdominal pain resulting from prolonged, frequent cannabis use.
You might actually have Hyperemesis Gravidarum. What is Hyperemesis […] Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways ...
Hyperemesis gravidarum (HG) is a pregnancy complication that is characterized by severe nausea, vomiting, weight loss, and possibly dehydration. [1] Feeling faint may also occur. [ 2 ] It is considered a more severe form of morning sickness . [ 2 ]
Symptoms of hyperemesis gravidarum include extreme nausea and vomiting. Like Kate Middleton, this mom was hospitalized for it. I had hyperemesis gravidarum during both my pregnancies.
Hyperemesis gravidarum affects about one in every 200 pregnancies and results in severe nausea, dehydration, and low blood pressure, among other things.
Please go to the hyperemesis gravidarum talk page if you have an opinion about whether cannabinoids can or should be mentioned in that article's subsection for related to antiemetic medicines. (Hyperemesis gravidarum is a severe form of nausea and vomiting in pregnancy.) Medical marijuana was first mentioned in the article in 2007 but a small ...